Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 186

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 186
---
       - |     |                    |    - | % |     |          |     | % |
| Mr. ‌Arie ‌ Gordashnikov                                    |     |              |       - |     |                    |    - | % |     |          |     | % |
| Mt. Efraim Cohen-Arazi                                      |     |              |       - |     |                    |    - | % |     |          |     | % |
| All directors and executive officers as a group (8 persons) |     |              | 535,280 |     |                    | 33.5 | % |     |          |     | % |

| * | Indicates beneficial ownership of less than 1% of the 
 total Ordinary Shares outstanding.                    |

<div align='center'>114</div>

| (1) | Consists of 246,643 Ordinary Shares. The beneficial owners under HaisThera Scientific Fund I, L.P. are: Faith Reliance International Limited (LP) with 39% beneficial ownership, Waifull Industries Limited (LP) with 26% beneficial ownership, Haisco Pharmaceutical Co., Limited (LP) with 18% beneficial ownership, Vista Associates Corporation (LP) with 5% beneficial ownership, Mooi Management Limited (LP) with 5% beneficial ownership, MA WEI (LP) with 5% beneficial ownership. The beneficial owner under Faith Reliance International (LP) is Wang Junmin. The beneficial owner under Waifull Industries Limited (LP) is Fan Xiulian. The beneficial owners under Haisco Pharmaceutical Co., Limited (LP) are Wang Junmin, Fan Xiulian and Zheng Wei. The business address of this stockholder is PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands. |

| (2) | Consists of: (1) 118,549 Ordinary Shares and (2) 13,217 warrants exercisable into 13,217 Ordinary Shares. The beneficial owner under Ocorian Fund Management S.à r.l., acting for and on behalf of Generali Financial Holdings FCP-FIS Sub-Fund 2 is Ocorian Holdings (Europe) S.à r.l., which owns 100% of Ocorian Fund Management S.à r.l. Thomas Fahl, Frederic Pierre Jose Michels and Simon Burgess are the acting and controlling managers of Ocorian Fund Management S.à r.l.